← Leaderboards
Daniel S Pilch
Univ Of Med/Dent Nj-R W Johnson Med Sch
$3,377,045
Attributed
$3,377,045
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $392.7K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,377,045 · 3
By mechanism
R01$2,984,391 · 2
R56$392,654 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Med/Dent Nj-R W Johnson Med Sch
Same institution · by research overlap
- Huizhou Fan$3,194,946
- Leroy F Liu$9,409,862
- Hisako Masuda$105,268
- William N Hait$3,322,304
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyDrug TargetingDrug ResistanceDoseDrug CandidateDrug KineticsBacteriaAntibiotic ResistanceAntibioticsDesignCytochrome P450Anti-Bacterial AgentsCardiotoxicityAreaCell DivisionCellsCenters For Disease Control And Prevention (U.S.)Bacterial Drug ResistanceBacterial InfectionsClinical PracticeCombined Modality TherapyBactericideBenchmarkingEnsure
Grant awards (10)
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus$391,347
R01 · FY2020 · AI · contact PI
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus$391,311
R01 · FY2019 · AI · contact PI
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus$391,277
R01 · FY2018 · AI · contact PI
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus$391,244
R01 · FY2017 · AI · contact PI
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus$391,212
R01 · FY2016 · AI · contact PI
Development of New Antibiotics against Multidrug-Resistant Staphylococcus aureus$392,654
R56 · FY2015 · AI · contact PI
DNA Minor Groove-Targeting Anticancer Agents$252,443
R01 · FY2006 · CA · contact PI
DNA Minor Groove-Targeting Anticancer Agents$258,519
R01 · FY2005 · CA
DNA Minor Groove-Targeting Anticancer Agents$258,519
R01 · FY2004 · CA
DNA Minor Groove-Targeting Anticancer Agents$258,519
R01 · FY2003 · CA